BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Policy

  RedHill Biopharma Ltd. Provides Update on Planned NDA Filing for RHB-102 (Once Daily Anti-Emetic) in Q1 2014 and Commences PK Program

  July 11, 2013

   · 

  1 min read
• BioCapital

  Accelovance Primed to Achieve Leadership in Oncology Clinical Trials

  July 11, 2013

   · 

  4 min read
• Drug Development

  ALK-Abello A/S Release: Positive Results From Pivotal Phase III Trial of New Allergy Immunotherapy Tablet Against House Dust Mite-Induced Allergic Asthma

  July 11, 2013

   · 

  1 min read
• Genetown

  Merrimack Pharmaceuticals Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes

  July 11, 2013

   · 

  1 min read
• Biotech Bay

  Comprehend Partners With Sequoia Capital and Raises $8.4 Million

  July 11, 2013

   · 

  1 min read
• Business

  Applied Instrument Technologies Announces New Addition to Technical Leadership Team

  July 11, 2013

   · 

  2 min read
• Business

  Tianjin Weikai In-licenses China Rights to 3D Cell Culture System From Zyoxel

  July 11, 2013

   · 

  1 min read
• Business

  PharmAkea, Celgene Corporation and Bay City Capital Collaborate to Advance Innovative Oral Therapies to Benefit Patients With Cancer and Fibrotic Disease

  July 11, 2013

   · 

  4 min read